Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of PuraStat for intraoperative bleeding in laparoscopic or robotic gastrectomy
jRCTs042240001Completed
- Start
- Apr 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of PuraStat in gastric cancer (GC) and postoperative hemorrhage. Primary endpoint: Percentage of hemostasis achieved in 3 minutes after PuraStat use. Started Apr 2024; status: completed.
02
Drugs
PuraStat
03
Conditions
gastric cancer (GC)postoperative hemorrhage
Beyond the preview
Go deeper on jRCTs042240001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs042240001.